phone icon (917) 310-3371 Explore MAT Treatment Menu
close menu
Nao Medical Logo

Suboxone covered by Medicaid in NYC

Find Suboxone and buprenorphine treatment with Medicaid, Medicare, commercial insurance, or self-pay review across NYC and Long Island.

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters.

NYC Health identifies buprenorphine as a medication for opioid use disorder and notes that Medicaid, Medicare, and most health plans pay for it. Individual benefits still need verification before care is finalized.

Nao Medical clinic visit
Nao Medical clinic interior
Nao Medical patient care
Coverage should be clear before treatment starts The goal is a practical plan: confirm benefits, understand visit and pharmacy pieces, then schedule the right local or virtual follow-up.

What Medicaid patients should know

Insurance can support treatment, but the details matter. A strong Suboxone plan checks the visit, testing, pharmacy, medication, and follow-up pieces together.

Medicaid plan review

Coverage can involve the medical visit, urine drug screening, pharmacy benefits, medication copays, and prior authorization. Verifying benefits before the plan starts prevents avoidable surprises.

Common Medicaid managed-care pathways

Patients often ask about Healthfirst, MetroPlus, Fidelis, UnitedHealthcare Community Plan, and other New York Medicaid managed-care plans. Acceptance and benefits should be checked for the individual patient.

Medication plus follow-up

Suboxone care is not only the prescription. The visit should also cover timing, safety, monitoring, follow-up cadence, and what to do if withdrawal or cravings change.

Telemedicine plus local backup

Virtual care can reduce friction for the right patient, while nearby locations remain important for exams, testing, injection options, or in-person follow-up.

Kratom dependence and withdrawal

Patients using Kratom or concentrated 7-OH products can request an addiction-medicine evaluation. A clinician reviews the product, amount, timing, withdrawal symptoms, other opioid exposure, and safety risks.

Suboxone is not FDA approved specifically for Kratom dependence. Any buprenorphine treatment must be individualized and may be off-label. Treatment is not automatic, and another approach may be recommended.

Do not choose a dose or start time from online instructions. Kratom leaf, extracts, concentrated 7-OH, other opioid exposure, current withdrawal, and prior buprenorphine history can change the plan.

Review Kratom dependence treatment and intake.

Official treatment context

Medication treatment for opioid use disorder is evidence-based care. Patients can review public guidance from NYC Health, FDA, and New York OASAS. For Kratom safety and regulatory context, review FDA and Kratom.

Local MAT access across NYC and Long Island

Related MAT options

Medicaid and Suboxone questions

NYC Health states that Medicaid, Medicare, and most health plans pay for buprenorphine. Coverage details still depend on the specific Medicaid managed-care plan, visit type, pharmacy benefits, urine drug screening, and prior authorization rules.
Many Medicaid managed-care plans are accepted for addiction medicine visits. The care team should verify benefits before the plan moves forward because coverage can differ by plan and service.
Telemedicine may be available when clinically appropriate and when the payer requirements can be met. Some patients still need an in-person visit, lab work, or local follow-up.
Coverage can vary, and self-pay options may be available when a patient chooses that route. For patients using a self-pay path for Suboxone-based care, current self-pay pricing is $350 for the initial visit including UDS, $200 for follow-up visits including UDS, and $100 for a short bridge visit when clinically appropriate.
Nao Medical can evaluate Kratom dependence and withdrawal. Suboxone is not FDA approved specifically for Kratom dependence, so treatment is not automatic. A clinician must assess the product, symptoms, other substances, prior opioid exposure, and whether an individualized off-label buprenorphine plan or another approach is appropriate.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

The visit was private, clear, and focused on what I needed to do next.

Verified Patient
(4.9)

They helped me understand medication timing and follow-up without making me feel judged.

Verified Patient
(4.9)

Insurance questions were handled before the plan moved forward.

Verified Patient
(4.9)

The team explained telemedicine and in-person follow-up in a way that made sense.

Verified Patient
(4.9)

I left with clearer next steps and a realistic appointment plan.

Verified Patient
(4.9)

The clinic made a difficult appointment feel organized and respectful.

Focused care or a more supported outpatient program

Nao Medical operates a New York State OASAS-certified outpatient addiction treatment program. The first visit can focus on the immediate clinical question and medication planning when relevant, or the care plan can include counseling, recovery support, and closer follow-up when that is wanted or clinically recommended.

Focused clinical visits

Patients can request a private evaluation centered on the immediate concern, prescribing or injection planning when applicable, monitoring, and practical next steps. Medication is never automatic; eligibility and safety still require clinician review.

Counseling is available

Patients who want more support can add counseling, relapse-prevention work, care coordination, and recovery follow-up through the outpatient addiction program.

Confidential intake first

After scheduling, complete the confidential addiction intake form when it is sent. It helps the team review current substance use, prior treatment, medications, insurance, and the safest visit type.

Nao Medical accepts Medicaid and many major insurance plans, including Medicare, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare and UnitedHealthcare Community Plan, EmblemHealth, Aetna, Cigna, and Blue Cross Blue Shield. Coverage varies by visit, medication, pharmacy benefit, testing, counseling, and prior authorization. Review addiction-treatment insurance support.

Health information notice

General information only. The information here is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.

Content was updated August 4, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.